Materials • Major Chemicals
$93.27 ▼ -3.69
(-3.81%)
MKT CAP: $11.01B • VOL: 2.46M
52W L $88 52W H $221
ALB // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.14B | $5.38B | $9.62B |
| YoY Revenue Growth % | -4.4% | -44.1% | — |
| Gross Profit | $668.7M | $62.5M | $4.23B |
| Gross Margin % | 13.0% | 1.2% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$367.1M | -$1.78B | $251.9M |
| Operating Margin % | -7.1% | -33.0% | 2.6% |
| Net Income (GAAP) | -$510.6M | -$1.18B | $1.57B |
| EBITDA (Normalized) | $104.8M | -$432.1M | $598.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.28B | $687.9M | $1.33B |
| Capital Expenditures (CapEx) | $589.8M | $1.68B | $432.8M |
| Free Cash Flow (FCF) | $692.5M | -$992.7M | $893.8M |
| FCF Margin % | 13.5% | -18.5% | 9.3% |
| Return on Invested Capital (ROIC %) | -2.6% | -11.8% | 2.9% |
| Cash & Short-Term Equivalents | $1.62B | $1.19B | $1.27B |
| Total Debt (Short + Long Term) | $3.12B | $3.12B | $2.70B |
| Total Stockholders' Equity | $9.53B | $9.96B | $5.54B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ALB.